Press Coverage

From Trading Floors to Cellular Therapy: Diederik van der Reijt's Vision

Former trader turned biotech entrepreneur Diederik van der Reijt leads breakthrough developments in cellular rejuvenation technology at Celljevity.

HealthTech Zone

External Publication

Read Original Article
From Trading Floors to Cellular Therapy: Diederik van der Reijt's Vision

From Trading Floors to Cellular Therapy: Diederik van der Reijt's Vision

This profile piece from HealthTech Zone explores our CEO's journey from finance to biotech and his vision for making longevity medicine accessible.

The article highlights how former trader turned biotech entrepreneur Diederik van der Reijt leads breakthrough developments in cellular rejuvenation technology at Celljevity.

Read the full article on HealthTech Zone

Medical Disclaimer: Celljevity's Prometheus technology is investigational and not FDA-approved. Research protocol options vary by jurisdiction. Individual results may vary. Not evaluated by the FDA. Not intended to diagnose, treat, cure, or prevent disease. Consult your healthcare provider.